Delivery Order SPE2DB20D3101-SPE2DB23FQUR5

Award Date 11/14/22
Potential Completion Date 11/15/22
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,505.60 firm-fixed-price contract is for the delivery of MUCINEX ER 600 MG TABLET 500S. This order is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This federal contract award, valued at $1,386.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mucinex ER 600 mg tablets in quantities of 20s and has a completion date of February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $9,238.75, is for the delivery of Mucinex ER 600 mg tablets. The award is not set aside for any particular business type. It is a firm fixed-price contract for medical supplies to support military treatment facilities and other federal healthcare programs. Amerisourcebergen Drug Corp holds a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,743.85, is for the delivery of Mucinex ER 600 mg tablets in quantities of 500. This is a firm fixed-price delivery order contract with a completion date of December 29, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award, valued at $1,059.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Mucinex D ER 600-60 MG Tablet 36S, a pharmaceutical product. The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Mucinex ER 600 mg tablets. The total ceiling value of the contract is $1,840.50, with a period of performance through April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MUCINEX ER 600 MG TABLET 20S. The contract is a Firm Fixed Price delivery order with a ceiling value of $1,691.53 and an ultimate completion date of September 4, 2024. The contract is not set aside for any specific business type. This order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex ER 1,200 mg tablets. The contract has a ceiling value of $2,108.01 and a period of performance through April 24, 2025. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex ER 600 mg tablets and has a ceiling value of $2,367.68. The contract type is firm fixed price and the performance period extends through April 30, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,190 units of Mucinex ER 600 mg tablets, a prescription medication. The contract has a firm fixed price of $3,497.90 and a period of performance through May 9, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQUR5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Mucinex ER 600 mg tablets in quantities of 20 per package. The award ceiling value is $1,272.05 and the ultimate completion date is November 15, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC enables efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract award did not have a set-aside designation, indicating full and open competition.

Generated 2/27/25, 12:07 PM